Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study

A Banerjee, D A Lane, C Torp-Pedersen, G Y H Lip

    270 Citationer (Scopus)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab